Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuTCV vs Typbar-TCV Immunogenicity and Safety Study
NCT04830371Phase 3Completed
- Sponsor
- EuBiologics
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of EuTYPH-C in typhoid fever, sponsored by EuBiologics. Started Sep 2020; status: completed.
02
Drugs
EuTYPH-C
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT04830371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04830371.